2021 Innovation Discovery Grants Awarded

Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring.

Read More: https://www.massgeneralbrigham.org/newsroom/press-releases/innovation-discovery-grants-awarded-mass-general-brigham-scientific-0

Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD, Brigham and Women’s Hospital

Novel Strategies to Enhance Tfr Treatment of Autoimmunity, Peter Sage, PhD, Brigham and Women’s Hospital

Long-Lasting mRNA Therapy for Genetic Disorders, Jinjun Shi, PhD, Brigham and Women’s Hospital

AAV-Based Gene Replacement Therapy Improves Targeting and Clinical Outcomes in a Childhood CNS Disorder, Yulia Grishchuk, PhD, Massachusetts General Hospital

Towards a Permanent Genetic Cure for Spinal Muscular Atrophy, Benjamin Kleinstiver, PhD, Massachusetts General Hospital

Differentiation of Retinal Neurons for Cell Replacement in Glaucoma, Petr Baranov, MD, PhD, Massachusetts Eye and Ear